| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.750 | 8.985 | 10.595 | 10.283 | 9.725 | 9.086 | 8.612 | 19.700 | 29.000 | 36.679 |
| Total Income - EUR | 7.750 | 8.985 | 10.595 | 10.283 | 9.725 | 9.086 | 8.612 | 24.262 | 29.745 | 36.679 |
| Total Expenses - EUR | 6.830 | 6.665 | 8.247 | 7.556 | 6.159 | 4.998 | 8.715 | 10.316 | 17.503 | 18.367 |
| Gross Profit/Loss - EUR | 920 | 2.320 | 2.348 | 2.727 | 3.567 | 4.088 | -103 | 13.946 | 12.242 | 18.312 |
| Net Profit/Loss - EUR | 688 | 2.050 | 2.030 | 2.516 | 3.335 | 3.838 | -217 | 13.753 | 11.972 | 15.820 |
| Employees | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Expertomed Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 1.462 | 1.458 | 755 | 97 | 0 | 0 | 0 |
| Current Assets | 12.896 | 14.590 | 16.476 | 16.996 | 19.975 | 19.019 | 19.155 | 27.273 | 25.226 | 31.415 |
| Inventories | 51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.046 | 701 | 1.512 | 999 | 865 | 962 | 891 | 11.593 | 3.142 | 16.380 |
| Cash | 11.799 | 13.889 | 14.964 | 15.997 | 19.110 | 18.056 | 18.264 | 15.680 | 22.084 | 15.035 |
| Shareholders Funds | 12.437 | 14.361 | 16.148 | 18.367 | 21.346 | 19.404 | 18.757 | 26.255 | 24.438 | 30.069 |
| Social Capital | 157 | 156 | 153 | 150 | 148 | 145 | 142 | 142 | 142 | 141 |
| Debts | 458 | 229 | 328 | 153 | 90 | 370 | 496 | 1.018 | 787 | 1.346 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6920 - 6920" | |||||||||
| CAEN Financial Year |
6920
|
|||||||||
Comments - Expertomed Company Srl